Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations

By sjmartinez • June 22, 2023

Usman MS, Siddiqi TJ, Anker SD, Bakris GL, Bhatt DL, Filippatos G, Fonarow GC, Greene SJ, Januzzi JL Jr, Khan MS, Kosiborod MN, McGuire DK, Piña IL, Rosenstock J, Vaduganathan M, Verma S, Zieroth S, Butler J. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations. J Am Coll Cardiol. 2023 Jun 27;81(25):2377-2387. doi: 10.1016/j.jacc.2023.04.034. PMID: 37344038.

Tags: cardiovascular death, General Internal Medicine, heart failure hospitalization, Publications, sodium-glucose cotransporter-2 inhibitors

Evolving growth hormone deficiency: proof of concept

Chimatapu SN, Sethuram S, Samuels JG, Klomhaus A, Mintz C, Savage MO, Rapaport R. Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024[...]

Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men

Zabihollahy F, Miao Q, Naim S, Sonni I, Vangala S, Kim H, Hsu W, Sisk A, Reiter R, Raman SS, Sung K. Investigating MRI-Associated Biological[...]

A structured approach to modifying an implementation package while scaling up a complex evidence-based practice

Cordasco KM, Gabrielian SE, Barnard J, Harris T, Finley EP. A structured approach to modifying an implementation package while scaling up a complex evidence-based practice.[...]